Literature DB >> 23139514

Hypercalcemia in patients of oral squamous cell carcinoma.

P V Nimonkar1, R M Borle.   

Abstract

PURPOSE: This study was performed to measure the total and ionic serum calcium levels and incidence of hypercalcemia in patients with Oral Squamous Cell Carcinoma (OSCC) and its clinical significance and relevance.
MATERIALS AND METHODS: A randomly selected sample of seventy patients of histologically confirmed Oral Squamous Cell Carcinoma (OSCC) at any of the standard clinical stages were included. Fasting blood samples were obtained for measuring serum calcium levels. The elevated values of serum calcium levels were correlated with clinical features of hypercalcemia to draw inference.
RESULTS: Total serum calcium was found to be elevated in 12 patients (17.4%) and serum ionic calcium was elevated in 3 patients (4.29%).
CONCLUSION: The data suggests that hypercalcemia occurred in advanced stages of oral squamous cell carcinoma and its management may be relevant in providing terminal care and prolonging the life span of the patients.

Entities:  

Keywords:  Hypercalcemia; Oral squamous cell carcinoma

Year:  2009        PMID: 23139514      PMCID: PMC3454227          DOI: 10.1007/s12663-009-0056-1

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  9 in total

1.  Hypercalcemia in neoplastic disease.

Authors:  W P MYERS
Journal:  Arch Surg       Date:  1960-02

2.  Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients.

Authors:  S H Ralston; S J Gallacher; U Patel; J Campbell; I T Boyle
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

3.  Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases.

Authors:  Nicolas Penel; Céline Berthon; Frédéric Everard; Jean-Charles Neu; Stéphanie Clisant; Michèle N'guyen; Stéphanie Villet; Charles Fournier; Jean-Louis Lefebvre
Journal:  Oral Oncol       Date:  2005-10       Impact factor: 5.337

4.  The cellular basis of metastatic bone disease in patients with lung cancer.

Authors:  S F Cramer; L Fried; K J Carter
Journal:  Cancer       Date:  1981-12-15       Impact factor: 6.860

5.  Frequency of the hypercalcemia-leukocytosis syndrome in oral malignancies.

Authors:  T Yoneda; R Nishimura; I Kato; M Ohmae; M Takita; M Sakuda
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

6.  Hypercalcemia in head and neck carcinoma. Incidence and prognosis.

Authors:  C Won; D A Decker; A Drelichman; M Al-Sarraf; M L Reed
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

Review 7.  A practical approach to hypercalcemia.

Authors:  Mary F Carroll; David S Schade
Journal:  Am Fam Physician       Date:  2003-05-01       Impact factor: 3.292

Review 8.  Assessment and management of patients with abnormal calcium.

Authors:  Charlotte Eielson Ariyan; Julie Ann Sosa
Journal:  Crit Care Med       Date:  2004-04       Impact factor: 7.598

Review 9.  The hypercalcemia of malignancy: pathogenesis and management.

Authors:  G R Mundy; T J Martin
Journal:  Metabolism       Date:  1982-12       Impact factor: 8.694

  9 in total
  1 in total

1.  Serum alkaline phosphatase in oral squamous cell carcinoma and its association with clinicopathological characteristics.

Authors:  Swetha Acharya; Jyoti Kale; Pragati Rai; Venkatesh Anehosur; Kaveri Hallikeri
Journal:  South Asian J Cancer       Date:  2017 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.